nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—penis—type 1 diabetes mellitus	0.0586	0.234	CbGeAlD
Pentoxifylline—ADORA1—nerve—type 1 diabetes mellitus	0.0255	0.102	CbGeAlD
Pentoxifylline—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.0173	0.0565	CcSEcCtD
Pentoxifylline—NT5E—retina—type 1 diabetes mellitus	0.0172	0.0684	CbGeAlD
Pentoxifylline—NT5E—nephron tubule—type 1 diabetes mellitus	0.0162	0.0644	CbGeAlD
Pentoxifylline—NT5E—cardiovascular system—type 1 diabetes mellitus	0.0145	0.0579	CbGeAlD
Pentoxifylline—NT5E—kidney—type 1 diabetes mellitus	0.0142	0.0566	CbGeAlD
Pentoxifylline—NT5E—pancreas—type 1 diabetes mellitus	0.0141	0.0563	CbGeAlD
Pentoxifylline—NT5E—lymphoid tissue—type 1 diabetes mellitus	0.0122	0.0486	CbGeAlD
Pentoxifylline—PDE5A—retina—type 1 diabetes mellitus	0.0111	0.0444	CbGeAlD
Pentoxifylline—ADORA2A—cardiovascular system—type 1 diabetes mellitus	0.0104	0.0412	CbGeAlD
Pentoxifylline—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00943	0.0307	CcSEcCtD
Pentoxifylline—PDE5A—cardiovascular system—type 1 diabetes mellitus	0.00943	0.0376	CbGeAlD
Pentoxifylline—PDE4B—islet of Langerhans—type 1 diabetes mellitus	0.00914	0.0364	CbGeAlD
Pentoxifylline—ADORA1—cardiovascular system—type 1 diabetes mellitus	0.00894	0.0356	CbGeAlD
Pentoxifylline—ADORA1—kidney—type 1 diabetes mellitus	0.00874	0.0348	CbGeAlD
Pentoxifylline—ADORA2A—lymphoid tissue—type 1 diabetes mellitus	0.0087	0.0347	CbGeAlD
Pentoxifylline—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00869	0.0283	CcSEcCtD
Pentoxifylline—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00814	0.0265	CcSEcCtD
Pentoxifylline—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00788	0.0257	CcSEcCtD
Pentoxifylline—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00774	0.0252	CcSEcCtD
Pentoxifylline—Purpura—Ramipril—type 1 diabetes mellitus	0.00731	0.0238	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00728	0.0237	CcSEcCtD
Pentoxifylline—PDE4B—pancreas—type 1 diabetes mellitus	0.00643	0.0256	CbGeAlD
Pentoxifylline—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00599	0.0195	CcSEcCtD
Pentoxifylline—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00593	0.0193	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00584	0.019	CcSEcCtD
Pentoxifylline—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00579	0.0189	CcSEcCtD
Pentoxifylline—PDE4B—lymphoid tissue—type 1 diabetes mellitus	0.00556	0.0221	CbGeAlD
Pentoxifylline—Jaundice—Ramipril—type 1 diabetes mellitus	0.0053	0.0173	CcSEcCtD
Pentoxifylline—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00528	0.0172	CcSEcCtD
Pentoxifylline—Sweating—Ramipril—type 1 diabetes mellitus	0.00521	0.017	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00514	0.0167	CcSEcCtD
Pentoxifylline—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00512	0.0167	CcSEcCtD
Pentoxifylline—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00488	0.0159	CcSEcCtD
Pentoxifylline—Flushing—Ramipril—type 1 diabetes mellitus	0.00453	0.0147	CcSEcCtD
Pentoxifylline—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0044	0.0144	CcSEcCtD
Pentoxifylline—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00436	0.0142	CcSEcCtD
Pentoxifylline—Erythema—Ramipril—type 1 diabetes mellitus	0.00425	0.0138	CcSEcCtD
Pentoxifylline—Tension—Ramipril—type 1 diabetes mellitus	0.00417	0.0136	CcSEcCtD
Pentoxifylline—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00416	0.0135	CcSEcCtD
Pentoxifylline—Nervousness—Ramipril—type 1 diabetes mellitus	0.00412	0.0134	CcSEcCtD
Pentoxifylline—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00408	0.0133	CcSEcCtD
Pentoxifylline—Tremor—Ramipril—type 1 diabetes mellitus	0.00398	0.013	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00394	0.0128	CcSEcCtD
Pentoxifylline—Agitation—Ramipril—type 1 diabetes mellitus	0.0039	0.0127	CcSEcCtD
Pentoxifylline—Angioedema—Ramipril—type 1 diabetes mellitus	0.00388	0.0126	CcSEcCtD
Pentoxifylline—Malaise—Ramipril—type 1 diabetes mellitus	0.00383	0.0125	CcSEcCtD
Pentoxifylline—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0038	0.0124	CcSEcCtD
Pentoxifylline—Palpitations—Ramipril—type 1 diabetes mellitus	0.00375	0.0122	CcSEcCtD
Pentoxifylline—Convulsion—Ramipril—type 1 diabetes mellitus	0.00368	0.012	CcSEcCtD
Pentoxifylline—Chest pain—Ramipril—type 1 diabetes mellitus	0.00361	0.0118	CcSEcCtD
Pentoxifylline—Myalgia—Ramipril—type 1 diabetes mellitus	0.00361	0.0118	CcSEcCtD
Pentoxifylline—Anxiety—Ramipril—type 1 diabetes mellitus	0.0036	0.0117	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00359	0.0117	CcSEcCtD
Pentoxifylline—Discomfort—Ramipril—type 1 diabetes mellitus	0.00357	0.0116	CcSEcCtD
Pentoxifylline—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00353	0.0115	CcSEcCtD
Pentoxifylline—Confusional state—Ramipril—type 1 diabetes mellitus	0.00349	0.0114	CcSEcCtD
Pentoxifylline—Oedema—Ramipril—type 1 diabetes mellitus	0.00346	0.0113	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00346	0.0113	CcSEcCtD
Pentoxifylline—Shock—Ramipril—type 1 diabetes mellitus	0.00341	0.0111	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00339	0.0111	CcSEcCtD
Pentoxifylline—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00338	0.011	CcSEcCtD
Pentoxifylline—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00337	0.011	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00335	0.0109	CcSEcCtD
Pentoxifylline—Anorexia—Ramipril—type 1 diabetes mellitus	0.0033	0.0108	CcSEcCtD
Pentoxifylline—Hypotension—Ramipril—type 1 diabetes mellitus	0.00324	0.0106	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00316	0.0103	CcSEcCtD
Pentoxifylline—Insomnia—Ramipril—type 1 diabetes mellitus	0.00313	0.0102	CcSEcCtD
Pentoxifylline—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00309	0.0101	CcSEcCtD
Pentoxifylline—Somnolence—Ramipril—type 1 diabetes mellitus	0.00308	0.01	CcSEcCtD
Pentoxifylline—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00305	0.00994	CcSEcCtD
Pentoxifylline—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00301	0.00982	CcSEcCtD
Pentoxifylline—Constipation—Ramipril—type 1 diabetes mellitus	0.00296	0.00966	CcSEcCtD
Pentoxifylline—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00286	0.0093	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00283	0.00923	CcSEcCtD
Pentoxifylline—Urticaria—Ramipril—type 1 diabetes mellitus	0.00275	0.00897	CcSEcCtD
Pentoxifylline—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00274	0.00893	CcSEcCtD
Pentoxifylline—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00274	0.00893	CcSEcCtD
Pentoxifylline—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00255	0.00832	CcSEcCtD
Pentoxifylline—Asthenia—Ramipril—type 1 diabetes mellitus	0.00249	0.0081	CcSEcCtD
Pentoxifylline—Pruritus—Ramipril—type 1 diabetes mellitus	0.00245	0.00799	CcSEcCtD
Pentoxifylline—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00237	0.00773	CcSEcCtD
Pentoxifylline—Dizziness—Ramipril—type 1 diabetes mellitus	0.00229	0.00747	CcSEcCtD
Pentoxifylline—Vomiting—Ramipril—type 1 diabetes mellitus	0.0022	0.00718	CcSEcCtD
Pentoxifylline—Rash—Ramipril—type 1 diabetes mellitus	0.00218	0.00712	CcSEcCtD
Pentoxifylline—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00218	0.00711	CcSEcCtD
Pentoxifylline—Headache—Ramipril—type 1 diabetes mellitus	0.00217	0.00707	CcSEcCtD
Pentoxifylline—Nausea—Ramipril—type 1 diabetes mellitus	0.00206	0.00671	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000385	0.000871	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000384	0.000868	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000383	0.000867	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000383	0.000866	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000381	0.000861	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000381	0.000861	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000379	0.000858	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000378	0.000856	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000373	0.000843	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000372	0.000842	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000371	0.00084	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000369	0.000833	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000368	0.000832	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.000362	0.000819	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000361	0.000816	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000359	0.000812	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000358	0.00081	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000357	0.000807	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000357	0.000807	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000356	0.000806	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000356	0.000805	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000355	0.000802	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000354	0.000801	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000354	0.000801	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000352	0.000797	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000352	0.000797	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000349	0.00079	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000349	0.000789	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000348	0.000786	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000345	0.000779	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—INS—type 1 diabetes mellitus	0.000344	0.000779	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000344	0.000778	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000344	0.000777	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000335	0.000758	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000334	0.000755	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000333	0.000754	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000331	0.000749	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000331	0.000749	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000331	0.000749	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000331	0.000749	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000329	0.000744	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000323	0.000731	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000322	0.000727	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000321	0.000727	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000317	0.000717	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000317	0.000717	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000317	0.000717	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ALB—type 1 diabetes mellitus	0.000316	0.000714	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000313	0.000707	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000313	0.000707	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000305	0.00069	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000303	0.000685	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000303	0.000685	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000303	0.000684	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NOS3—type 1 diabetes mellitus	0.000302	0.000683	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000301	0.000681	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000301	0.00068	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000301	0.00068	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000297	0.000673	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000297	0.000672	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000296	0.00067	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000296	0.000669	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000293	0.000664	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000293	0.000662	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000291	0.000657	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000289	0.000655	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000289	0.000654	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	0.000289	0.000653	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000289	0.000653	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000288	0.000651	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000288	0.000651	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000284	0.000642	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000283	0.000641	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000282	0.000637	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000282	0.000637	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00028	0.000633	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000278	0.00063	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000278	0.00063	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000278	0.000629	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000278	0.000629	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000277	0.000627	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000275	0.000623	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000275	0.000623	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00027	0.00061	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000269	0.000609	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000268	0.000607	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000266	0.000603	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000266	0.000601	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000264	0.000597	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000263	0.000594	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000263	0.000594	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000259	0.000586	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000259	0.000585	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000258	0.000583	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000253	0.000572	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000253	0.000572	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000249	0.000564	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SST—type 1 diabetes mellitus	0.000247	0.000559	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000246	0.000557	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000244	0.000552	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000243	0.00055	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000242	0.000548	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000242	0.000546	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000235	0.000532	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000232	0.000526	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000229	0.000518	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000226	0.000512	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000226	0.000511	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00022	0.000498	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.00022	0.000498	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00022	0.000497	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000219	0.000496	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000219	0.000496	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000219	0.000495	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000218	0.000492	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000217	0.000492	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000217	0.000492	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000212	0.00048	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000211	0.000478	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00021	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000208	0.000471	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000206	0.000466	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000205	0.000465	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000205	0.000464	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000204	0.00046	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000203	0.000459	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000202	0.000456	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.0002	0.000453	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.0002	0.000452	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000199	0.00045	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000194	0.00044	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000192	0.000434	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000191	0.000432	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00019	0.000431	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00019	0.00043	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000187	0.000424	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000187	0.000423	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000187	0.000422	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000185	0.000418	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000185	0.000418	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000184	0.000417	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000183	0.000414	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000183	0.000414	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000182	0.000412	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00018	0.000406	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000177	0.000401	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000173	0.000391	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000172	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00017	0.000385	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00017	0.000385	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00017	0.000385	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00017	0.000383	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000168	0.000381	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000168	0.000379	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000166	0.000376	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000164	0.00037	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000162	0.000366	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000162	0.000366	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00016	0.000362	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000159	0.00036	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000159	0.00036	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000159	0.000359	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000157	0.000356	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000157	0.000355	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000156	0.000352	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000155	0.000351	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000154	0.000348	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000154	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000146	0.000329	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000145	0.000327	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000144	0.000326	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000142	0.000321	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000141	0.000319	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.00014	0.000317	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00014	0.000316	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000139	0.000314	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000133	0.000302	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000132	0.0003	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000132	0.000299	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000132	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000131	0.000296	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.00013	0.000294	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000129	0.000293	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000128	0.000289	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000128	0.000289	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000127	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000125	0.000283	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INS—type 1 diabetes mellitus	0.000124	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000123	0.000278	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000122	0.000277	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000121	0.000274	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00012	0.000272	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.00012	0.000271	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000119	0.000269	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000118	0.000268	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000118	0.000267	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000118	0.000266	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000116	0.000262	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000116	0.000261	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000111	0.00025	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000109	0.000247	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000109	0.000246	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000108	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000108	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000108	0.000244	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000107	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000101	0.000229	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.84e-05	0.000223	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—type 1 diabetes mellitus	9.83e-05	0.000222	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.78e-05	0.000221	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INS—type 1 diabetes mellitus	9.56e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.25e-05	0.000209	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.22e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—type 1 diabetes mellitus	9.2e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.2e-05	0.000208	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.16e-05	0.000207	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	9.14e-05	0.000207	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	9.11e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.11e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—type 1 diabetes mellitus	9.09e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.05e-05	0.000205	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.54e-05	0.000193	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.38e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.28e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.27e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.74e-05	0.000175	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	7.71e-05	0.000174	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.65e-05	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.52e-05	0.00017	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	7.26e-05	0.000164	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	7.22e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.12e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.11e-05	0.000161	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	7.09e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.07e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.04e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.95e-05	0.000157	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.53e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	6.36e-05	0.000144	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.98e-05	0.000135	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—type 1 diabetes mellitus	5.78e-05	0.000131	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	5.65e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.43e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—type 1 diabetes mellitus	5.41e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—type 1 diabetes mellitus	5.35e-05	0.000121	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.78e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.18e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.17e-05	7.18e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.91e-05	6.58e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.78e-05	6.29e-05	CbGpPWpGaD
